Moffitt Cancer Center
Avatar

Recognizing Signs and Symptoms of Gastric Cancer Progression: How to Look at It, How to Have Conversations With Patients, Conversations With Peers, When to Switch to 2L Treatment

By Moffitt Cancer Center FEATURING Rutika Mehta
By Moffitt Cancer Center FEATURING Rutika Mehta
178 views
July 28, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
19:39
Vanderbilt University Medical Center (VUMC)

Helicobacter Pylori: A Bacterium That Causes Gastric Cancer

Feat. R. Peek
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
27:12
Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
23:27
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…

Feat. R. Kim, R. Mehta
19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

18:51
Hope for Stomach Cancer

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Feat. D. Catenacci
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

16:53
Scripps MD Anderson Cancer Center

GC/GEJC/EC Trials - Evolving Landscape and Treatment Guidance

Feat. J. Hecht
23:26
Yale Cancer Center

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Feat. C. Balch
10:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Randomized Phase 3 GASTFOX Study - 5-fluor…

Feat. A. Zaanan
04:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Biomarker Analysis of 2 Zolbetuximab Phas…

Feat. K. Shitara
03:31
ecancer

ESMO 2023 Summary: "Highlights From Recent GI Cancer Trials&quo…

Feat. B. Gyawali
08:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 ATTRACTION-5 Study - Nivo + Chemo…

Feat. M. Terashima
06:39
Oncology Data Advisor

Additional Advances in Esophagogastric Cancer Research and Clinical …

Feat. J. Ajani
11:02
ASCO GI 2023 Conference Coverage

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

Feat. Y. Y. Janjigian
18:55
ImmunoTherapy Bridge 2023

Immunotherapy in GI Cancer: Current Treatment Landscape and Challeng…

Feat. A. Avallone
47:17
Scripps Health

Update on GI Cancers: Focus on Prevention and Screening

Feat. W. Coyle